A core slide library with comprehensive slide notes, plus 'ready-to-download' presentations.
NEW core library slide now available.
Ready-to-go Meeting Presentations
Fertility and pregnancy in the patient with inflammatory bowel disease
Uma Mahadevan-Velayos, MD
This activity is supported by a grant from UBC, Inc.- Pouchitis: A unique form of IBD
Bo Shen, MD
This activity is supported by a grant from UCB, Inc. - Biologic therapy for IBD: Which patient, which biologic, and risks of treatment?
Stephen B. Hanauer, MD
This activity is supported by a grant from UCB, Inc. - New insights into the pathophysiology of inflammatory bowel disease: Identifying targets beyond TNF
Scott E. Plevy, MD
This activity is supported by a grant from UCB, Inc. - Long-term biologic therapy in Crohn's disease
Remo Panaccione, MD, FRCPSC
This activity is supported by a grant from UCB, Inc.
View all CME active Slide Libraries
Archive (CME-expired materials)
How do I use biologic therapy in my pediatric IBD patients?
Elizabeth J. Hait, MD, MPH
This activity is supported by an educational grant from Abbott Laboratories.- What are the options in the management of my ulcerative colitis patient?
Bret Lashner, MD
This activity is supported by a grant from UCB, Inc. - Strategies for managing patients with Crohn's perianal fistulas
David A. Schwartz, MD
This activity is supported by a grant from UCB, Inc.
View all CME active Curbside Consults and Clinical Decision Maps
Expert commentary based on the latest published data with downloadable PowerPoint slides illustrating the key information.
Assessing treatment response and mucosal healing: The role of capsule endoscopy
Shabana F. Pasha, MD, Jonathan A. Leighton, MD
This activity is supported by an educational grant from Given Imaging.- The role of capsule endoscopy in diagnosing small bowel disease
Peter Legnani, MD
This activity is supported by a grant from Given Imaging. - Gender issues in the male IBD patient
Sunanda V. Kane, MD
This activity is supported by a grant from UCB, Inc. - Role of mucosal healing: Impact on patient-related outcomes
Paul Rutgeerts, MD, PhD
This activity is supported by a grant from UCB, Inc. - Are Crohn's disease and ulcerative colitis mutually exclusive?
Dermot P.B. McGovern, MB BS, D. Phil (Oxford)
This activity is supported by a grant from UCB, Inc.




Summarized by Corey Siegel, MD
This activity is supported by an educational grant from UCB, Inc.
- Infliximab, azathioprine, or combination therapy for Crohn's disease
Colombel JF, Sandborn WJ, Reinisch W, et al. - Once-daily dosing of delayed-release oral mesalamine (400 mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis
Sandborn WJ, Korzenik J, Lashner B, et al. - Reinduction with certolizumab pegol in patients with relapsed Crohn's disease: Results from the PRECiSE 4 study
Sandborn WJ, Schreiber S, Hanauer SB, et al. - Left-sided dysplasia progresses more rapidly than right-sided dysplasia to advanced neoplasia (AN) in patients with ulcerative colitis (UC)
Goldstone R, Itzkowitz S, Harpaz N, Ullman T. - Aminosalicylates, thiopurines and the risk of colorectal cancer in inflammatory bowel diseases: A case-control study nested in the CESAME cohort
Carrat F, Seksik P, Bouvier A, et al. - Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis
Reinisch W, Sandborn W, Hommes D, et al. - Naltrexone therapy improves activity and promotes mucosal healing in active Crohn’s disease: A placebo-controlled trial
Smith J, Bingaman S, Ruggiero F, et al. - Double-blind, placebo-controlled, Phase IIB trial of HMPL-004 (Andrographis Paniculata Extract) in active mild-to-moderate ulcerative colitis (UC)
Sandborn W, Targan S, Byers V, Yan X, Tang T.


Please provide us with your comments and feedback about this site.






